Quantified pathway mutations associate epithelial-mesenchymal transition and immune escape with poor prognosis and immunotherapy resistance of head and neck squamous cell carcinoma
Pathway mutations have been calculated to predict the poor prognosis and immunotherapy resistance in head and neck squamous cell carcinoma (HNSCC). To uncover the unique markers predicting prognosis and immune...
Source: BMC Medical Genomics - Category: Genetics & Stem Cells Authors: Yuhong Huang, Han Liu, Bo Liu, Xiaoyan Chen, Danya Li, Junyuan Xue, Nan Li, Lei Zhu, Liu Yang, Jing Xiao and Chao Liu Tags: Research Source Type: research
More News: Cancer & Oncology | Carcinoma | Epithelial Cancer | Genetics | HNSCC | Immunotherapy | Skin Cancer | Squamous Cell Carcinoma